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Synthetic peptides corresponding to the N-terminal of the cleaved hemagglutinin (HA2) of influenza virus induce an in- 
crease in conductance of planar phospholipid bilayers, and cause the release of encapsulated molecules from large unila- 
mellar liposomes. Two mutant peptides, derived from hemagglutinins of mutant viruses with no or reduced fusion activi- 
ty, do not alter the membrane conductance significantly. These observations upport the hypothesis that influenza virus 
fuses with its target membrane by inserting the HA2 N-terminal into the membrane. 
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1. INTRODUCTION 
Influenza virus is thought to infect its host cell 
by fusion with the endosome membrane, following 
endocytosis and acidification of the endosome 
lumen, thereby releasing its nucleocapsid into the 
cytoplasm [l-4]. The virus can also induce cell-cell 
fusion at mildly acidic pH [5,6], or fuse with target 
membranes such as liposomes and erythrocytes 
[7-lo]. Fusion is mediated by the hemagglutinin 
(HA) glycoprotein of the viral envelope, but only 
after proteolytic cleavage of the protein into the 
HA1 and HA2 subunits [6,7,10-131. At low pH, 
the HA molecule changes its conformation [ 14,151, 
binds to liposomes of various lipid composition 
[14,16,17], and induces hemolysis and liposome 
lysis [ 181. The insertion of the N-terminal 
hydrophobic segment of the HA2 into the target 
membrane has been suggested to be the mechanism 
by which the glycoprotein induces the fusion of the 
viral envelope with the target membrane 
[4,7,10,13,14]. The observation that tetrapeptides 
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corresponding to this segment inhibit the infectivi- 
ty of influenza virus also supports the hypothesis 
that the HA2 N-terminal interacts with the cell 
membrane during fusion [ 191. Here, we present he 
first direct evidence that the N-terminal peptide 
segment of HA2 can interact with phospholipid 
membranes in a manner sufficient to perturb the 
barrier properties of the membranes. We have in- 
vestigated the interaction of synthetic peptides cor- 
responding to the N-terminal sequence of 
influenza X : 31 HA2 with planar bilayers and 
liposomes. We have found that the 7-amino acid 
peptide HA2.7 (table 1) induces discrete conduc- 
tance spikes in planar Montal-Miiller membranes 
and causes the leakage of encapsulated compounds 
from large unilamellar liposomes. 
2. MATERIALS AND METHODS 
Solvent-free planar membranes were formed across a hole of 
approx. 80~m diameter on a thin (25 pm) teflon septum by 
raising the level of phospholipid monolayers pread on aqueous 
media on both sides of the septum [20,21]. Membranes were 
made from soybean asolectin (type II-S, Sigma) purified ac- 
cording to Kagawa and Racker [22], or egg phosphatidyl- 
ethanolamine (Avanti Polar Lipids, Birmingham, AL). The 
aqueous medium was 100 mM KCl, 10 mM Hepes, pH 7.0. The 
110 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/88/$3.50 0 1988 Federation of European Biochemical Societies 
Volume 227, number 2 FEBS LETTERS January 1988 
conductance of the membranes was measured by using a con- 
ventional voltage clamp system. The signal was filtered with a 
low-pass filter of a band-width of 2 kHz, processed by a SONY 
PCM-Fl , and stored on video recorder tapes [23]. The signal 
was continuously monitored on an oscilloscope and an 
oscillographic paper recorder (Hewlett Packard 7402A). The 
peptides were synthesized by Biosearch, Inc. (San Rafael, CA), 
and by Dr Andras Patthay (Biomolecular Resource Center, 
UCSF), using the Merrifield solid-phase technique [24] with an 
Applied Biosystems 430A peptide synthesizer. HPLC analysis 
indicated the purity to be 90%, and amino acid analysis re- 
vealed the expected composition. The peptides were suspended 
in the KCl/Hepes buffer at a concentration of 1 mg/ml and 
sonicated for 30 s using a probe sonifier. 
Large unilamellar liposomes of an average diameter of 
140 nm (determined by dynamic light scattering in a Coulter 
particle analyzer) were prepared by reverse-phase evaporation, 
followed by extrusion through polycarbonate membranes with 
a pore size of 100 nm [25,26]. The effect of peptides on 
liposome membrane permeability was determined by moni- 
toring the leakage into the medium of co-encapsulated ANTS 
(8-aminonaphthalene-1,3,6-trisulfonic acid) and its collisional 
quencher DPX (N,N’-p-xylylenebis(pyridinium bromide) 
[27,28]. Both compounds were supplied by Molecular Probes 
(Eugene, OR). The liposomes contained 12.5 mM ANTS, 
45 mM DPX, 10 mM Hepes, pH 7.0, and sufficient NaCl to ad- 
just the osmolality to that of the medium (100 mM KCl, 10 mM 
Hepes, pH 7.0). Leakage results in the dilution of the com- 
pounds in the medium, and in an increase of ANTS fluo- 
rescence, since quenching by DPX is concentration-dependent. 
Egg phosphatidylcholine and bovine brain phosphatidylserine 
were obtained from Avanti Polar Lipids. Fluorescence was 
measured in an SLM-4000 fluorometer, using a Corning 3-68 
high-pass filter, with the excitation wavelength at 360 nm. The 
fluorescence scale was set to 100% by lysing the vesicles 
(50 nmol lipid/ml) with 0.8 mM n-dodecyl octaethylene mono- 
ether. 
3. RESULTS 
3.1. Hemagglutinin peptides induce conductance 
fluctuations in planar bilayers 
When HA2.7 was added to one side of a planar 
membrane, composed either of asolectin or 
phosphatidylethanolamine, discrete conductance 
spikes were observed (fig.la). Decreasing the pH 
to 5 did not alter significantly the conductance 
behavior of the membranes. In some cases, super- 
position of conductance spikes gave rise to a 
macroscopic conductance increase (fig. la). The 
applied voltage in the righthand section of trace a 
was reduced to 10 mV to be able to follow the in- 
crease in membrane conductance. In fig.2, the 
specific conductance, G, is plotted as a function of 
time on a bilogarithmic scale, and the data can be 
fitted with a straight line. The relationship G = 
G(O)t” suggests that the conductance is determined 
by the aggregation of several (n) molecules of pep- 
tide, if the concentration of monomers in the mem- 
brane increases linearly with time, and the 
aggregation process is very fast with respect o the 
incorporation process [29,30]. The current-voltage 
characteristics revealed an overlinearity when 
negative voltages were applied to the chamber op- 
posite that containing the peptide, i.e. the trans 
side (fig.3). This was particularly evident im- 
mediately after the addition of the peptide when 
the ionic conductance was lower. At higher 
permeability the Z-V characteristics tended to 
become more symmetric, with the overlinearity 
evident at both positive and negative voltages. 
3.2. Mutant peptides do not alter the membrane 
conductance significantly 
Gething et al. [31] have recently produced in- 
fluenza virus mutants by site-directed mutagenesis 
of the hemagglutinin. Fusion activity of the virus 
was eliminated when glutamic acid was substituted 
for the glycine at the N-terminus of HA2. The effi- 
ciency of fusion was reduced, and the pH 
threshold was raised, when glutamic acid was 
substituted for the glycine at position 4. We have 
examined the effects on planar membrane conduc- 
tance of 7-amino acid peptides corresponding to 
these mutant proteins. The first of the mutant pep- 
tides, HA2.7mul (table l), was essentially ineffec- 
tive in causing conductance fluctuations or an 
overall increase in conductance, although occa- 
sional spikes were observed (fig.lb). The second 
mutant peptide, HA2.7mu4, was much less effec- 
tive than the wild type peptide, but did cause con- 
ductance spikes (fig.lc). The percent of time, 7, 
that the membrane current in the presence of the 
peptides was higher than the steady-state value is 
shown in table 2. 
Addition of HA2.17 to planar membranes at the 
Table 1 
N-terminal peptides of influenza virus hemagglutinin HA2 used 
in this study 
Peptide Amino acid sequence 
HA2.7 Gly-Leu-Phe-Gly-Ala-Ile-Cys 
HA2.7mul Glu-Leu-Phe-Gly-Ala-Be-Cys 
HA2.7mu4 Gly-Leu-Phe-Glu-Ala-Be-Cys 
HA2.17 Gly-Leu-Phe-Gly-Ala-Ile-Ala-Gly-Phe- 
Be-Glu-Asn-Gly-Trp-Glu-Gly-Cys 
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Fig.1. Typical current traces of asolectin membranes in the 
presence of peptides from hemagglutinin and its mutants. 
Peptides were added to the chamber on one side of the 
membrane (the cis side) at 50&ml (left-hand arrow). (a) 
HA2.7; (b) HA2.7mul; (c) HA2.7mu4. The initial applied 
voltage, represented by the lower trace in each section, was 
always - 100 mV; the voltage was periodically inverted. The 
sign of the voltage is that of the truns compartment (not 
containing the peptide) with respect to the cis side. Note that the 
magnitude of the applied voltage in the righthand section of 
trace a is 10 mV. The behavior of the current immediately after 
the addition of the peptide (lefthand arrow) and after (a) 8 min, 
(b) 55 min, and (c) 11 min (righthand arrow) is shown. 
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Fig.2. The specific conductance of a planar bilayer composed 
of asolectin, as a function of the time after the addition of 
50 ,ug/ml HA2.7, plotted on a bilogarithmic scale. The straight 
line obtained by the best fit of the experimental points indicates 
that the specific conductance increases as a power of time 
(n = 4.3). The applied voltage was 100 mV. 
same molar concentration as the HA2.7 produced 
no change in the membrane conductance in three 
experiments over several hours of recording; in one 
experiment a r value of 1.2% was obtained over a 
total observation time of 3260 s. To ensure that the 
membrane would have responded to the insertion 
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Fig.3. Current response to a continuous cycled voltage from 
- 140 to - 140 mV, recorded in the presence of 50pg/ml of 
HA2.7. 
of the HA2.17, HA2.7 was added to the chamber 
at the end of the observation period and invariably 
caused a conductance increase. 
3.3. Hemagglutinin peptides cause the release of 
aqueous contents from liposomes 
Addition of HA2.7 to a suspension of liposomes 
composed of asolectin or phosphatidylserine/ 
phosphatidylcholine (1: 1) induced the release of 
encapsulated ANTSIDPX, whereas HA2.7mul 
and HA2.7mu4 were essentially ineffective. The 
initial rate of release from phosphatidylserine/ 
phosphatidylcholine liposomes in the presence of 
20 or 50 pg/ml HA2.7 was 3.1 and 9.0% maximal 
fluorescence/min, respectively. In contrast, with 
50 pg/ml HA2.7mu4 or HA2.7mul the initial rate 
was 0.1 and 0.05% maximal fluorescence/min, 
respectively. Consistent with the planar bilayer ex- 
periments, these observations indicate that the 
permeability barrier of the liposome membrane 
was disrupted by the interaction of the HA2.7 with 
the lipid bilayer. 
Table 2 
The percent of time, z, the membrane current is higher in the 
presence of peptides, than the steady-state value observed in 
their absence 
Peptide 7 (o/o time) Observation 
time (s) 
HA2.7 75.5 5310 
HA2.7mul 1.6 5445 
HA2.7mu4 2.8 6000 
The peptide concentrations were 50yg/ml. The data were 
derived from experiments performed at an applied voltage of 
100 mV. Experiments performed at different voltages produced 
similar results 
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4. DISCUSSION 
Our observations with planar bilayers indicate 
that synthetic peptides corresponding to the N- 
terminal hydrophobic sequence of the hemag- 
glutinin of influenza virus cause transient pertur- 
bations of the phospholipid bilayer structure, 
allowing for the conductance to increase momen- 
tarily and return to the steady-state level. The per- 
turbations may be caused by the lateral and 
head-to-tail self-aggregation of the peptides in the 
membrane. The conductance fluctuations and in- 
crease may not be specific for hemagglutinin N- 
terminal peptides, since it is quite likely that a com- 
bination of equally hydrophobic amino acid 
residues could produce similar results. Since 
repetitive, step-like conductance transitions typical 
of single channels were not observed, the increase 
of the baseline current in the presence of the pep- 
tide is likely to be caused by the extensive insertion 
of the peptides into the membrane and the local 
disorganization of the lipid bilayer structure. 
The different efficiency of peptides tested can be 
explained by the lower hydrophobicity of the 
17-amino acid peptide and of the two mutants, in 
comparison with that of HA2.7. According to the 
hydrophobic scale of Eisenberg et al. [32], HA2.7 
has a hydrophobicity of 0.79 per amino acid, while 
the two mutants and HA2.17 present 
hydrophobicities of 0.61 and 0.48, respectively. 
We should note that the inability of HA2.17 to af- 
fect conductance changes does not necessarily 
mean that it does not interact with the membrane. 
The N-terminal segment of HA2.17 could have in- 
serted into the membrane without causing a con- 
ductance increase. The rest of the peptide could be 
resting in the aqueous phase, because of its lower 
hydrophobicity, and thus may not be able to 
penetrate the bilayer. If the conductance increase is 
caused by the self-aggregation of several peptides, 
as proposed above, it is possible that the inserted 
segment is not able to associate with other peptides 
in the membrane. The binding of 16- and 20-amino 
acid peptides from influenza B/Lee/40 to 
sonicated phosphatidylcholine vesicles has been 
reported [33]. On the other hand, when HA2.17 is 
initially dissolved in a guanidine-ethanol mixture 
and added to phospholipid vesicles, it does cause 
extensive lysis (unpublished), suggesting that the 
conformation of the peptide in water is not par- 
titularly conducive to alteration of membrane con- 
ductance. 
The current-voltage asymmetry observed im- 
mediately after the addition of HA2.7 can be inter- 
preted as a potential-driven incorporation of the 
peptide into the membrane, particularly favored at 
high negative voltages. Peptide molecules crossing 
the lipid bilayer would tend to balance the peptide 
concentration difference between the two sides of 
the membrane, giving rise to a progressive sym- 
metrization of the conductance increase and the 
overlinear behavior. 
The insertion of the peptides into the membrane 
occurs at pH 7. This observation suggests that once 
the hydrophobic N-terminal of HA2 is exposed as 
a result of the pH-induced conformational change 
of the hemagglutinin, it is prone to insert into the 
target membrane, if the latter is physically accessi- 
ble. The inability of one of the mutant viruses 
(mul) to fuse [31] may thus be explained by our 
observation that the N-terminal peptide derived 
from this mutant (HA2.7mul) cannot interact with 
target membranes. The low efficiency of fusion of 
the second mutant is also consistent with the low 
frequency of interaction of its N-terminal peptide 
with planar membranes (table 2). How the penetra- 
tion of the N-terminal of HA2 into the target mem- 
brane mediates membrane fusion is not known. 
We should note that the conformation of the N- 
terminal peptide in the intact protein may be dif- 
ferent from that of the free peptide in solution, 
and that correlations such as we have obtained 
may not always hold. 
Low pH-induced fusion of influenza virus with 
erythrocyte ghosts can be arrested by restoration 
of the pH to neutral and re-initiated by reducing 
the pH a second time [8]. Assuming that the low 
pH-induced conformational change of HA is ir- 
reversible [14,18], continuous protonation of the 
acidic groups in the N-terminal region of HA2 
would appear to be necessary for fusion. However, 
the above observation on virus-ghost fusion may 
also be explained if fusion is mediated by the pro- 
cess of conformational change of HA2 when the 
pH is lowered, and not by the final equilibrium 
conformation of the protein at low pH. Thus, 
when the pH is returned to neutral, HA2 molecules 
in the irreversible low-pH conformation would not 
be able to induce fusion. If the HA2 molecules of 
a population of virus particles had not undergone 
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the conformational change during the initial low- 
pH treatment, these virus particles may have been 
responsible for the fusion reaction observed when 
the pH was lowered a second time. 
Ohnishi and Murata [34] have reported that a 
20-amino acid peptide from influenza A/PR/8/34 
induces fusion of small unilamellar phosphatidyl- 
choline vesicles at low pH. The sequence of this 
peptide is different from that of HA2.17, with a 
glycine substituted for asparagine in position 12 
and a threonine substituted for glutamic acid at 
position 15. In contrast, the 16-amino acid peptide 
from influenza B/Lee/40 does not induce fusion 
of sonicated palmitoyloleylphosphatidylcholine 
vesicles, whereas the 20-amino acid peptide has 
pH-independent membrane fusion activity [33]. 
HA2.17 from influenza X : 3 1, however, does not 
mediate the fusion of small unilamellar phosphati- 
dylcholine vesicles, at pH 7 or 5 (Dtizgunes, N. and 
Parente, R., unpublished). Thus, minor variations 
in peptide length and composition appear to in- 
fluence the fusogenic activity of peptides derived 
from influenza hemagglutinin. 
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